United Kingdom · Question · Written question
UIN 189730
Medicines and Healthcare products Regulatory Agency
Introduced
14 June 2023
Last action
23 June 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Healthcare
Source updated
23 June 2023
Summary
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency plans to consult representatives of (a) patient organisations and (b) the pharmaceutical industry on its plans for new regulatory rec
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 June 2023
Written question
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency plans to consult representatives of (a) patient organisations and (b) the pharmaceutical industry on its plans for new regulatory rec
Source: Commons
23 June 2023
Answer
Regarding the first part of the question on consultation with patient organisations, the Medicines and Healthcare products Regulatory Agency (MHRA) held a workshop on 3 November 2022 to obtain patient views on the MHRA’s proposals for a new International ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-06-14/189730
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1644840
- uk · wq-1644840 · source updated 23 June 2023